Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Nov 23 EFFECT Notice of effectiveness
- 8 Nov 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
18 Oct 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 28 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 18 Aug 23 S-4 Registration of securities issued in business combination transactions
NGNE similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 18, 2023, in Amendment No. 2 to the Registration Statement (Form S-4 No. 333-274095) and related proxy statement/prospectus of Neoleukin Therapeutics, Inc.
/s/ Ernst & Young LLP
Stamford, Connecticut
October 18, 2023